{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:40:46Z","timestamp":1789141246105,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.expneurol.2022.114207","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:44:48Z","timestamp":1660711488000},"page":"114207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["P2X7 receptor as a potential therapeutic target for perinatal brain injury associated with preterm birth"],"prefix":"10.1016","volume":"357","author":[{"given":"Emily","family":"Zucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2022.114207_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1476-5381.2010.01025.x","article-title":"Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat","volume":"162","author":"Able","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114207_bb0010","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.09-153601","article-title":"Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor","volume":"24","author":"Adinolfi","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2022.114207_bb0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: a main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.expneurol.2022.114207_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0025","first-page":"787","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.expneurol.2022.114207_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2010.05.107","article-title":"Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X 7 receptor","author":"Beswick","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2022.114207_bib384","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2018.00030","article-title":"Recent advances in CNS P2X7 physiology and pharmacology: focus on neuropsychiatric disorders","volume":"9","author":"Bhattacharya","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jri.2016.11.008","article-title":"Preterm birth: inflammation, fetal injury and treatment strategies","volume":"119","author":"Boyle","year":"2017","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0045","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.108.141853","article-title":"Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl) methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation","volume":"327","author":"Broom","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114207_bb0050","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/jnr.22368","article-title":"Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain","volume":"88","author":"Burd","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2022.114207_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818817494","article-title":"Purine and purinergic receptors","volume":"2","author":"Burnstock","year":"2018","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.expneurol.2022.114207_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acs.jmedchem.7b01279","article-title":"A dipolar cycloaddition reaction to access 6-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines enables the discovery synthesis and preclinical profiling of a P2X7 antagonist clinical candidate","volume":"61","author":"Chrovian","year":"2018","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114207_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.clp.2008.07.011","article-title":"Cytokines and perinatal brain damage","volume":"35","author":"Dammann","year":"2008","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/bs.apcsb.2015.11.004","article-title":"P2X7 receptor as a therapeutic target","volume":"104","author":"De Marchi","year":"2016","journal-title":"Adv. Prot. Chem. Struct. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2022.114207_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00039","article-title":"Non-nucleotide agonists triggering P2X7 receptor activation and pore formation","volume":"9","author":"Di Virgilio","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.mie.2019.07.043","article-title":"Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells","volume":"629","author":"Di Virgilio","year":"2019","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12624","article-title":"Introduction to the interleukin-1 family of cytokines and receptors: drivers of innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.expneurol.2022.114207_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2008.06.012","article-title":"[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors","volume":"56","author":"Donnelly-Roberts","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2022.114207_bb0100","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.4049\/jimmunol.172.8.4987","article-title":"A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release","volume":"172","author":"Elssner","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0105","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.173.7.4652","article-title":"The antibiotic polymyxin B modulates P2X7 receptor function","volume":"173","author":"Ferrari","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.expneurol.2022.114207_bb0110","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156468","article-title":"Critical evaluation of P2X7 receptor antagonists in selected seizure models","volume":"11","author":"Fischer","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.expneurol.2022.114207_bb0120","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.4049\/jimmunol.0903349","article-title":"IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation","volume":"184","author":"Girard","year":"2010","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.expneurol.2022.114207_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00123","article-title":"The P2X7 receptor-Interleukin-1 liaison","volume":"8","author":"Giuliani","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.expneurol.2022.114207_bb0130","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1933719116687656","article-title":"A role for the inflammasome in spontaneous preterm labor with acute histologic chorioamnionitis","volume":"24","author":"Gomez-Lopez","year":"2017","journal-title":"Reprod. Sci."},{"issue":"10","key":"10.1016\/j.expneurol.2022.114207_bb0135","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1933719116687656","article-title":"A role for the Inflammasome in spontaneous preterm labor with acute histologic chorioamnionitis","volume":"24","author":"Gomez-Lopez","year":"2017","journal-title":"Reprod. Sci. (Thousand Oaks, Calif.)"},{"key":"10.1016\/j.expneurol.2022.114207_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the nlrp3 inflammasome pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114207_bb0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","article-title":"The role of inflammation in perinatal brain injury","volume":"11","author":"Hagberg","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-017-0904-8","article-title":"The role of microglial P2X7: modulation of cell death and cytokine release","volume":"14","author":"He","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2022.114207_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2009.05.018","article-title":"The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1\u03b1\u03b2 knockout mice","volume":"204","author":"Honore","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"16","key":"10.1016\/j.expneurol.2022.114207_bb0160","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1089\/ars.2018.7636","article-title":"Connexin43 contributes to Inflammasome activation and lipopolysaccharide-initiated acute renal injury via modulation of intracellular oxidative status","volume":"31","author":"Huang","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","article-title":"Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses","volume":"9","author":"Jacob","year":"2013","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bib383","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","article-title":"Molecular and functional properties of P2X receptors\u2014recent progress and persisting challenges","volume":"8","author":"Kaczmarek-H\u00e1jeck","year":"2012","journal-title":"Purinergic Signal."},{"issue":"18","key":"10.1016\/j.expneurol.2022.114207_bb0170","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1523\/JNEUROSCI.5048-07.2008","article-title":"Connexin 43 hemichannels are permeable to ATP","volume":"28","author":"Kang","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114207_bib382","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2967\/jnumed.106.038539","article-title":"Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET","volume":"48","author":"Kannan","year":"2007","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.expneurol.2022.114207_bb0175","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1038\/ncomms10555","article-title":"Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1\u03b2 secretion in response to ATP","volume":"7","author":"Karmakar","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.expneurol.2022.114207_bb0180","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2022.114207_bb0185","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0192623310387619","article-title":"Microglia: key innate immune cells of the brain","volume":"39","author":"Kofler","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00183","article-title":"P2X7 interactions and signaling \u2013 making head or tail of it","volume":"12","author":"Kopp","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0092-8674(00)81282-9","article-title":"The gap junction communication channel","volume":"84","author":"Kumar","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.expneurol.2022.114207_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/aji.12216","article-title":"IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury","volume":"71","author":"Leitner","year":"2014","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y.\u202f: 1989)"},{"key":"10.1016\/j.expneurol.2022.114207_bib381","first-page":"419","article-title":"Synthesis and pharmacological characterization of two novel, brain penetrating P2X7 antagonists. ACS Med","volume":"4","author":"Letavic","year":"2013","journal-title":"Chem. Lett."},{"key":"10.1016\/j.expneurol.2022.114207_bb0210","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/acs.jmedchem.7b00408","article-title":"4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate","volume":"60","author":"Letavic","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2022.114207_bb0215","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.114.218487","article-title":"Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432","volume":"351","author":"Lord","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization","volume":"179","author":"McCarthy","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0225","first-page":"6","article-title":"Role of P2X7 receptors in release of IL-1\u03b2: a possible mediator of pulmonary inflammation","volume":"11","author":"Mortaz","year":"2012","journal-title":"Tanaffos."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","article-title":"Long-term medical and social consequences of preterm birth","volume":"359","author":"Moster","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbagen.2017.11.015","article-title":"The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release","volume":"1862","author":"Mugisho","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2022.114207_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2015.11.001","article-title":"A critical role of interleukin-1 in preterm labor","volume":"28","author":"Nadeau-Vall\u00e9e","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.expneurol.2022.114207_bb0245","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/jm051202e","article-title":"Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists","volume":"49","author":"Nelson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2022.114207_bb0250","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.clp.2018.01.015","article-title":"Perinatal brain injury: mechanisms, prevention, and outcomes","volume":"45","author":"Novak","year":"2018","journal-title":"Clin. Perinatol."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114207_bb0260","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/ijmr.IJMR_1624_14","article-title":"Interplay of cytokines in preterm birth","volume":"146","author":"Pandey","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.expneurol.2022.114207_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00200","article-title":"Perinatal brain injury as a consequence of preterm birth and intrauterine inflammation: designing targeted stem cell therapies","volume":"11","author":"Paton","year":"2017","journal-title":"Front. Neurosci."},{"issue":"21","key":"10.1016\/j.expneurol.2022.114207_bb0270","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/sj.emboj.7601378","article-title":"Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor","volume":"25","author":"Pelegrin","year":"2006","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1095\/biolreprod.114.124420","article-title":"Neutrophil recruitment and activation in decidua with intra-amniotic IL-1beta in the preterm rhesus macaque","volume":"92","author":"Presicce","year":"2015","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0173(99)00007-7","article-title":"Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function","volume":"30","author":"Raivich","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"14","key":"10.1016\/j.expneurol.2022.114207_bb0290","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.micinf.2012.07.006","article-title":"P2 receptors and immunity","volume":"14","author":"Rayah","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.expneurol.2022.114207_bb0295","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00003081-198809000-00006","article-title":"Infection and preterm labor","volume":"31","author":"Romero","year":"1988","journal-title":"Clin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9378(98)70271-6","article-title":"A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition","volume":"179","author":"Romero","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6198","key":"10.1016\/j.expneurol.2022.114207_bb0305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114207_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12440","article-title":"A role for the inflammasome in spontaneous labor at term","volume":"79","author":"Romero","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"262","key":"10.1016\/j.expneurol.2022.114207_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009871","article-title":"Prevention of preterm birth: harnessing science to address the global epidemic","volume":"6","author":"Rubens","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2022.114207_bb0320","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid {beta} requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2022.114207_bb0325","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00089","article-title":"Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists","volume":"6","author":"Savall","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2022.114207_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00052","article-title":"The P2X7 receptor in inflammatory diseases: angel or demon?","volume":"9","author":"Savio","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114207_bb0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","article-title":"The P2X7 receptor","volume":"1051","author":"Sluyter","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for Inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2022.114207_bb0350","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1021\/acs.jmedchem.6b00989","article-title":"Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a small molecule antagonist of the P2X7 receptor","volume":"59","author":"Swanson","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2022.114207_bb0355","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2967\/jnumed.116.181354","article-title":"Characterization of 11C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation","volume":"58","author":"Territo","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0360","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin. Perinatol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114207_bb0365","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/biolre\/iox081","article-title":"P2X7 receptor blockade prevents preterm birth and perinatal brain injury in a mouse model of intrauterine inflammation","volume":"97","author":"Tsimis","year":"2017","journal-title":"Biol. Reprod."},{"issue":"7","key":"10.1016\/j.expneurol.2022.114207_bb0370","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.3390\/ijms22073503","article-title":"Mechanisms underlying Connexin Hemichannel activation in disease","volume":"22","author":"Van Campenhout","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114207_bb0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/biom11010063","article-title":"Therapeutic Nanobodies targeting cell plasma membrane transport proteins: a high-risk\/high-gain endeavor","volume":"11","author":"Van Campenhout","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2022.114207_bb0380","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphys.2019.00141","article-title":"The role of connexin and pannexin channels in perinatal brain injury and inflammation","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Physiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:14:49Z","timestamp":1758003289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":80,"alternative-id":["S0014488622002321"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114207","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X7 receptor as a potential therapeutic target for perinatal brain injury associated with preterm birth","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114207"}}